More fake malaria drugs found in Africa

8 June 2008

Two years ago, the World Health Organization issued guidelines for new treatments against malaria because the existing drugs were becoming ineffective in curing the disease. In Uganda, artemisinin based combinations were introduced. However, the revelation that 35% of the antimalarial drugs purchased in the nation's pharmacies for testing were found to be fake or of poor quality is threatening to reverse the progress so far. Also, Kenya's Medical Services Minister Peter Anyang Nyong'o revealed that around 38% of antimalaria drugs in his country were substandard and 16% were fakes.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight